Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
5 participants
INTERVENTIONAL
2024-06-03
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Soft-robotic Glove Support of High-demand Tasks
NCT05318638
Effectiveness of Robot-assisted Rehabilitation in Persons With Stroke
NCT04002076
Effectiveness of Soft Robotic Glove Versus EMS on Hand Function and Quality of Life in Stroke Survivors (RCT)
NCT06739733
Therapy to Improve Reaching Movement in Upper Limb
NCT03508037
Improving Grasp Function in People With Sensorimotor Impairments by Combining Electrical Stimulation With a Robotic Hand Orthosis
NCT05976087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline phase
No interventions assigned to this group
Soft-robotic glove phase
Carbonhand
During this phase, participants use the Carbonhand soft-robotic glove system in daily life for 6 weeks to support the performance of daily activities with their affected hand in the home environment. The participants are free to choose for which activities, when and for how long they use the Carbonhand. However, it is recommended to use the Carbonhand at least 180 minutes a week during the most common ADL, such as household activities, dressing/undressing, eating/drinking/cooking, and/or leisure activities.
Retention phase
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbonhand
During this phase, participants use the Carbonhand soft-robotic glove system in daily life for 6 weeks to support the performance of daily activities with their affected hand in the home environment. The participants are free to choose for which activities, when and for how long they use the Carbonhand. However, it is recommended to use the Carbonhand at least 180 minutes a week during the most common ADL, such as household activities, dressing/undressing, eating/drinking/cooking, and/or leisure activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experience difficulties in performing ADL due to hand function limitations as a result of trauma-related injury or neurologic disorder
* Being in a chronic/stable phase of disease as judged by their physician
* Able to activate the soft-robotic glove by generating pressure on finger/palm sensors when grasping an object
* Ability to relax an active grip
* Sufficient cognitive status to understand two-step instructions
* Having (corrected to) normal vision
* Able to provide written informed consent
* Living independently
Exclusion Criteria
* Severe acute pain of the most-affected hand
* Wounds on the hands that can provide a problem when using the glove
* Severe contractures limiting passive range of motion to the extent that the glove can't be donned/activated comfortably
* Co-morbidities limiting functional use/performance of the arms and/or hands
* Severe spasticity of the hand (≥2 points on Ashworth Scale)
* Severe proximal weakness (MRC shoulder elevation\<4)
* Used the Carbonhand system in the past 3 months
* Participation in other studies that can affect functional performance of the arm/hand
* Receiving arm-/hand function therapy during the course of the study
* Insufficient digital literacy to conduct video calls
* Insufficient knowledge of the Dutch or English language to understand the purpose or methods of the study
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eurostars
OTHER
Roessingh Research and Development
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerdienke Prange, PhD
Role: PRINCIPAL_INVESTIGATOR
Roessingh Research and Development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roessingh Research and Development
Enschede, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
85214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.